Chenggang Gao

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Fospropofol disodium versus Propofol for deep sedation in critically ill patients: a randomized pilot study.

Fospropofol disodium versus Propofol for deep sedation in critically ill patients: a randomized pilot study.

Journal: BMC anesthesiology

Published: November 29, 2024

Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.

Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.

Journal: Cell & bioscience

Published: October 26, 2023

METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.

METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.

Journal: Cancer letters

Published: February 25, 2023

High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment.

High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment.

Journal: Journal of translational medicine

Published: December 09, 2022

Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management.

Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management.

Journal: Frontiers in immunology

Published: August 23, 2022

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases.

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases.

Journal: Frontiers in immunology

Published: August 05, 2022

Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: A retrospective cohort study.

Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: A retrospective cohort study.

Journal: Frontiers in cellular and infection microbiology

Published: June 06, 2022

MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.

MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.

Journal: Cytokine & growth factor reviews

Published: June 05, 2022

Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.

Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.

Journal: Cellular and molecular gastroenterology and hepatology

Published: March 09, 2022

NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression.

NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 07, 2022

A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.

A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.

Journal: Journal of translational medicine

Published: December 05, 2020

Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.

Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.

Journal: Cell & bioscience

Published: March 12, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026